User:Tkadm30/Notebook/Endocannabinoids/2-AG: Revision history

2 October 2018

• curprev 14:5814:58, 2 October 2018‎ Yar talk contribs‎ m 671 bytes 0‎ Yar moved page User:Etienne Robillard/Notebook/Endocannabinoids/2-AG to User:Tkadm30/Notebook/Endocannabinoids/2-AG: Automatically moved page while renaming the user "Etienne Robillard" to "Tkadm30"

14 January 2017

• curprev 05:0005:00, 14 January 2017‎ Tkadm30 talk contribs‎ 671 bytes +4‎ →‎Synopsis

7 November 2016

• curprev 03:5303:53, 7 November 2016‎ Tkadm30 talk contribs‎ 667 bytes −10‎ →‎2-arachidonoylglycerol (2-AG)
• curprev 03:5003:50, 7 November 2016‎ Tkadm30 talk contribs‎ 677 bytes −19‎ →‎Notes

2 June 2016

• curprev 05:5605:56, 2 June 2016‎ Tkadm30 talk contribs‎ 696 bytes +115‎ →‎See also
• curprev 05:5305:53, 2 June 2016‎ Tkadm30 talk contribs‎ m 581 bytes 0‎ User:Etienne Robillard/Notebook/2-AG moved to User:Etienne Robillard/Notebook/Endocannabinoids/2-AG

8 October 2015

• curprev 07:2407:24, 8 October 2015‎ Tkadm30 talk contribs‎ 581 bytes −465‎ →‎Notes

12 September 2015

• curprev 05:1805:18, 12 September 2015‎ Tkadm30 talk contribs‎ 1,046 bytes −3‎ →‎2-arachidonoylglycerol (2-AG)
• curprev 05:1705:17, 12 September 2015‎ Tkadm30 talk contribs‎ 1,049 bytes +137‎ →‎2-arachidonoylglycerol (2-AG)
• curprev 05:0505:05, 12 September 2015‎ Tkadm30 talk contribs‎ 912 bytes +912‎ New page: === 2-arachidonoylglycerol (2-AG) === A novel gliotransmitter controlled by the P2X7 receptor; 2-AG exert neuroprotective effects on excitotoxic brain injury. 2-AG is an endogenous can...